Chen Peng, Li Zhanzhan, Hu Yihe
Department of Orthopedic, Xiangya Hospital, Central South University, No.87, Xiangya Road, Kaifu District, Changsha City, Hunan Province, 410008, China.
Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
BMC Public Health. 2016 Oct 3;16(1):1039. doi: 10.1186/s12889-016-3712-7.
We conducted a systematic review and meta-analysis to obtain a reliable estimation of the prevalence of osteoporosis in China and to characterize its epidemiology.
We identified relevant studies via a search of literature published from 2003 to October 2015 in the PubMed, Web of Science, China National Knowledge Infrastructure, Wanfang and Weipu databases. Both Chinese and WHO criteria were considered acceptable for the diagnosis of osteoporosis. Prevalence estimates were obtained using random effects models. Meta-regression analysis was used to explore the sources of heterogeneity, and publication bias was evaluated by visually inspecting funnel plots.
Overall, 69 articles were included in this study. An obvious increase in the prevalence of osteoporosis was identified over the past 12 years (prevalence of 14.94 % before 2008 and 27.96 % during the period spanning 2012-2015). The prevalence of osteoporosis was higher in females than in males (25.41 % vs. 15.33 %) and increased with age. Osteoporosis prevalence was higher in rural than in urban areas (20.87 % vs. 23.92 %) and higher in southern than in northern areas (23.17 % vs. 20.13 %). At present, the pooled prevalence of osteoporosis in people aged 50 years and older was more than twice the pooled prevalence identified in 2006 (34.65 % vs. 15.7 %). The application of different diagnostic criteria could have an impact on prevalence estimation (19.7 % vs. 29.3 %). Meta-regression suggested that study setting also influenced the estimation of point prevalence (P = 0.022).
The prevalence of osteoporosis in China has increased over the past 12 years, affecting more than one-third of people aged 50 years and older. The prevalence of osteoporosis increased with age and was higher in females than in males. Prevention and control measures have become all the more important given the increase in osteoporosis prevalence, and three-step prevention programmes should be implemented.
我们进行了一项系统评价和荟萃分析,以获得中国骨质疏松症患病率的可靠估计值,并描述其流行病学特征。
我们通过检索2003年至2015年10月在PubMed、科学网、中国知网、万方和维普数据库中发表的文献来确定相关研究。中国标准和世界卫生组织标准均被视为诊断骨质疏松症的可接受标准。患病率估计采用随机效应模型。采用Meta回归分析探讨异质性来源,并通过直观检查漏斗图评估发表偏倚。
本研究共纳入69篇文章。在过去12年中,骨质疏松症患病率明显上升(2008年前患病率为14.94%,2012 - 2015年期间为27.96%)。女性骨质疏松症患病率高于男性(25.41%对15.33%),且随年龄增长而增加。农村地区骨质疏松症患病率高于城市地区(20.87%对23.92%),南方地区高于北方地区(23.17%对20.13%)。目前,50岁及以上人群骨质疏松症的合并患病率是2006年确定的合并患病率的两倍多(34.65%对15.7%)。不同诊断标准的应用可能会对患病率估计产生影响(19.7%对29.3%)。Meta回归表明研究背景也会影响时点患病率的估计(P = 0.022)。
在过去12年中,中国骨质疏松症患病率有所上升,影响了超过三分之一的50岁及以上人群。骨质疏松症患病率随年龄增长而增加,女性高于男性。鉴于骨质疏松症患病率的上升,预防和控制措施变得更加重要,应实施三级预防方案。